Physician profile
David E Curtis
NPI 1730222720
$1,840.39
in general payments reported to CMS, 2019-2025
12 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.62 · 2020: $1,137 · 2021: $228 · 2022: $234 · 2023: $94.82 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $201.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,546.22 | 2020-2025 | Pangea, Blueprint Patient Specific Instrumentation |
| Anika Therapeutics, INC. | $69.09 | 2021-2022 | |
| Lima USA, INC. | $39.62 | 2019 | |
| Ferring Pharmaceuticals INC. | $29.37 | 2021-2023 | Euflexxa |
| Vertex Pharmaceuticals Incorporated | $28.65 | 2025 | |
| Merck Sharp & Dohme LLC | $21.67 | 2022 | |
| Nevro Corp. | $21.48 | 2022 | |
| Depuy Synthes Sales INC. | $21.06 | 2022 | |
| Abbvie INC. | $18.27 | 2022 | |
| Bioventus LLC | $17.21 | 2023 | Exogen Ultrasound Bone Healing System |
| Endo Pharmaceuticals INC. | $14.36 | 2023 | Xiaflex |
| Globus Medical, INC. | $13.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Curtis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.